Abstract:Introduction: The mitochondria are important sources of reactive oxygen species (ROS) in the heart. Mitochondrial ROS production and subsequent oxidative damage have been implicated in the pathogenesis of diabetic cardiomyopathy. We hypothesized that therapeutic strategies specifically targeting mitochondrial ROS may have benefit in diabetic cardiomyopathy. Hypothesis: We hypothesized that therapeutic inhibition of mitochondrial ROS with mito-TEMPO reduces diabetic cardiomyopathy. Methods: The mitochondria-targeted antioxidant mito-TEMPO was administrated after diabetes onset in a mouse model of streptozotocin (STZ)-induced type-1 diabetes and type-2 diabetic db/db mice. Cardiac adverse changes were analyzed and myocardial function assessed. Cultured adult cardiomyocytes were stimulated with high glucose, and single mitochondrial superoxide generation and cell death were measured. Results: Incubation with high glucose increased mitochondria superoxide generation in cultured adult cardiomyocytes, which was prevented by mito-TEMPO. Co-incubation with mito-TEMPO also abrogated high glucose-induced cell death. Mitochondrial ROS generation, and intracellular ROS formation and oxidative damage were induced in both type-1 and type-2 diabetic mouse hearts. Daily injection of mito-TEMPO for 30 days inhibited mitochondrial ROS generation, prevented intracellular ROS formation and oxidative damage, decreased apoptosis and reduced myocardial hypertrophy in diabetic hearts without change of blood glucose, leading to improvement of myocardial function in both type-1 and type-2 diabetic mice. Mechanistic study revealed that the protective effects of mito-TMEPO were associated with down-regulation of ERK1/2 phosphorylation in diabetic hearts and high glucose-stimulated cardiomyocytes. Conclusions: Therapeutic inhibition of mitochondrial ROS by mitochondria-targeted antioxidant mito-TEMPO reduced adverse cardiac changes and mitigated myocardial dysfunction in both type-1 and type-2 diabetic mice. Thus, mitochondria-targeted antioxidants may be an effective therapy for diabetic cardiac complications.

Oxidative Damage of Mitochondrial Dna in Diabetes and Its Protection by Manganese Superoxide Dismutase

Diabetic Retinopathy, Superoxide Damage and Antioxidants.

Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy

Manganese Superoxide Dismutase Dysfunction and the Pathogenesis of Kidney Disease

Targeting Human 8-Oxoguanine DNA Glycosylase to Mitochondria Protects Cells from High Glucose-Induced Apoptosis.

Deacetylation of MnSOD by PARP-regulated SIRT3 Protects Retinal Capillary Endothelial Cells from Hyperglycemia-Induced Damage

Mitochondrial DNA Oxidative Damage Triggering Mitochondrial Dysfunction and Apoptosis in High Glucose-Induced HRECs

Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy.

Diabetic Retinopathy and Damage to Mitochondrial Structure and Transport Machinery.

Manganese Superoxide Dismutase: Guardian of the Powerhouse

The Impact of Oxidative Stress-Induced Mitochondrial Dysfunction on Diabetic Microvascular Complications.

Mitochondrial DNA transcription and mitochondrial genome-encoded long noncoding RNA in diabetic retinopathy

Insights into Manganese Superoxide Dismutase and Human Diseases

Mitochondria DNA Replication and DNA Methylation in the Metabolic Memory Associated with Continued Progression of Diabetic Retinopathy.

Overexpression of Manganese Superoxide Dismutase Protects Against Mitochondrial-Initiated Poly(Adp-Ribose) Polymerase-Mediated Cell Death

Diabetic Retinopathy and Regulation of Mitochondrial Glutathione–Glutathione Peroxidase Axis in Hyperhomocysteinemia

Manganese-induced single strand breaks of mitochondrial DNA in vitro and in vivo.

Methylglyoxal: A Key Factor for Diabetic Retinopathy and Its Effects on Retinal Damage

A Role for Diallyl Trisulfide in Mitochondrial Antioxidative Stress Contributes to Its Protective Effects Against Vascular Endothelial Impairment

Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion.

Abstract 13631: Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species With Mito-tempo Reduces Diabetic Cardiomyopathy